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“It’s very complicated”: a qualitative study of
medicines management in intermediate care
facilities in Northern Ireland
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Abstract
Background: Intermediate care (IC) describes a range of services targeted at older people, aimed at preventing
unnecessary hospitalisation, promoting faster recovery from illness and maximising independence. Older people
are at increased risk of medication-related adverse events, but little is known about the provision of medicines
management services in IC facilities. This study aimed to describe the current provision of medicines management
services in IC facilities in Northern Ireland (NI) and to explore healthcare workers’ (HCWs) and patients’ views of, and
attitudes towards these services and the IC concept.
Methods: Semi-structured interviews were conducted, recorded, transcribed verbatim and analysed using a constant
comparative approach with HCWs and patients from IC facilities in NI.
Results: Interviews were conducted with 25 HCWs and 18 patients from 12 IC facilities in NI. Three themes were
identified: ‘concept and reality’ , ‘setting and supply’ and ‘responsibility and review’. A mismatch between the concept
of IC and the reality was evident. The IC facility setting dictated prescribing responsibilities and the supply of medicines,
presenting challenges for HCWs. A lack of a standardised approach to responsibility for the provision of medicines
management services including clinical review was identified. Whilst pharmacists were not considered part of the
multidisciplinary team, most HCWs recognised a need for their input. Medicines management was not a concern for
the majority of IC patients.
Conclusions: Medicines management services are not integral to IC and medicine-related challenges are frequently
encountered. Integration of pharmacists into the multidisciplinary team could potentially improve medicines
management in IC.
Keywords: Intermediate care, Medicines management, Pharmacy, Older people, Qualitative
Background
Intermediate care (IC) is a care setting that has evolved
in response to the ageing population, the increasing
pressure faced by acute healthcare services and the
resulting need for alternatives to hospital-based care. Al-
though the term ‘IC’ originated in the United Kingdom
(UK), other countries have adopted similar strategies;
several equivalent healthcare models are used globally
and are denoted by a variety of terminologies including
‘sub-acute care’, ‘post-acute care’ and ‘transition care’ [1].
IC is broadly defined in the UK as ‘a range of integrated
services to prevent unnecessary hospital admission, pro-
mote faster recovery from illness, support timely discharge
and maximise independent living’ [2]. IC services may be
provided either in IC facilities or in the patient’s own
home. The types of individuals receiving IC and the key
principles of its provision are detailed in Table 1.
An integral component of IC is multidisciplinary team
involvement to meet patients’ care needs [2]. This ap-
proach has been credited with improving continuity of
patient care during the transition between healthcare
settings [3]. However, the role of pharmacists within IC
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has neither been defined nor evaluated, despite recogni-
tion that pharmacists’ skills may be of value in IC [4].
IC services are targeted towards an older population for
whom prescribed medicines comprise a fundamental com-
ponent of their care. Older patients are more likely to have
multiple morbidities for which they are prescribed numer-
ous medications, increasing their risk of experiencing
adverse drug events (ADEs) [5]. Additionally, up to 30 % of
hospital admissions in older adults are thought to be ADE-
related [6]. Such ADEs, the majority of which are thought
to be avoidable, are associated with considerable morbidity,
mortality and increased healthcare costs [7]. Furthermore,
the introduction of IC as a setting between primary and
secondary care has created an additional healthcare inter-
face across which medicines have to be managed. Receiving
care in numerous settings puts individuals at increased risk
of discontinuity of care in relation to medicines manage-
ment [8]. Due to these multiple factors, intrinsic to the IC
setting, it is therefore imperative that medicines manage-
ment is embedded within such services.
This study aimed to describe the current provision of
medicines management services in IC facilities in NI
and to explore healthcare workers’ (HCWs) and patients’
views of and attitudes towards this service along with
the overall concept of IC as a care setting. In addition,
this study sought to identify HCWs’ perceived barriers
and facilitators to the provision of medicines manage-
ment services.
Methods
Study design and recruitment
A qualitative study design, involving semi-structured in-
terviews, was adopted. Three of the five local public
authorities that manage and deliver health and social care
in NI (hereafter referred to as Trusts) were included. Only
those IC services that were provided in facilities were in-
cluded; thus those IC services provided to patients in their
own homes were not included. Of the Trusts not included,
one had no identifiable IC facility(s) at the time of the
study and there was on-going research in IC in the second
Trust. IC facilities with ≥5 beds in the three Trusts in-
volved were identified (n = 12), facility managers were
contacted by the researcher (AM), and all agreed to par-
ticipate. HCWs, defined as those with direct involvement
with medicines management within the facility were
eligible to participate. HCWs were recruited by letters dis-
tributed to all eligible staff working within the participat-
ing IC facilities. Patient participants were recruited via
nominated HCWs in each facility. The inclusion criteria
stipulated that at the time of the interview, patient partici-
pants were aged >18 years, present in the IC facility for a
minimum of two weeks, taking four or more regular med-
ications and did not have cognitive or communicative
impairment.
Interview schedules
A series of semi-structured interview schedules were de-
veloped, the content of which was informed by a litera-
ture review of the subject area1 and discussions within
the research team. The schedules differed slightly in
content and language used, depending on the interview’s
target group (see Fig. 1). The interview schedules were
then piloted to refine the content and ensure validity.
At the interview, HCWs were provided with a hard copy
of the key principles of IC (see Table 1) to aid discussion.
All interviews were undertaken following written, in-
formed consent and conducted by the researcher (AM),
trained in interview techniques. As interviews progressed,
emerging themes were identified and the interview sched-
ules were amended to explore new areas of interest. Re-
cruitment and data collection ceased when data saturation
was deemed to have occurred, noted as the appearance of
no new themes emerging with subsequent interviews.
Analysis
Data were transcribed verbatim, all identifiers were re-
moved and codes assigned to participants, and imported
to NVivo® to facilitate analysis, using a constant com-
parative approach frequently employed in this area of re-
search [9]. This method involves the simultaneous
coding and analysis of data in order to develop and re-
fine themes and explore their relationships to one an-
other [10]. By including both a variety of HCWs and
patients, the research question was explored from vari-
ous perspectives, a concept known as data triangulation;
such an approach has been credited with improving the
validity of qualitative study findings [11, 12]. The initial
Table 1 Overview of intermediate care, Department of Health
Social Services and Public Safety, Northern Ireland [39]
• Intermediate care services should be targeted at people who would
otherwise face:
– Inappropriate admission to acute in-patient care;
– Long-term residential/nursing home care;
– Unnecessary prolonged hospital stays; or
– Continuing in-patient care.
Key Principles:
• IC should be provided on the basis of a comprehensive person-centred
assessment of need, resulting in a structured individual care plan that,
where appropriate, involves active therapy, treatment or opportunity for
recovery;
• IC should have a planned outcome of maximising independence and
typically enabling service users to remain or resume living at home;
• IC should be time-limited, usually no longer than six weeks and
frequently as little as 1-2 weeks or less; and
• IC should involve cross-professional working, with a single assessment
framework, increasingly integrated professional records and shared
protocols.
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analysis was completed by one researcher (AM), with a
random sample of transcripts subjected to the same ana-
lysis by a second researcher (CR). Consensus on the
emergent themes was reached by discussion among all
three researchers (AM, CR, CH). Ethical approval was
granted by the Office for Research Ethics Committees
Northern Ireland (ORECNI) and governance approval
was provided by each of the three Trusts involved.
Results
Twelve IC facilities from three Trusts (A, B & C) were
recruited. These facilities varied in their organisational
characteristics, summarised in Table 2. A total of 43
participants (18 patients and 25 HCWs) were recruited
over a six month period from June 2013 - November
2013. Table 3 summarizes the demographic information
pertaining to all participants, who were assigned codes
according to the sequence of the interview. Interviews
with HCWs lasted, on average, 40 minutes, whilst pa-
tient interviews lasted 10-15 minutes. Three overarch-
ing themes were identified: ‘concept and reality’, ‘setting
and supply’ and ‘responsibility and review’. A mismatch
between the previously defined concept of IC and the
reality of the services provided in the facilities was
highlighted. The setting in which IC was delivered dic-
tated prescribing processes and the supply of medi-
cines, which presented a number of challenges for
HCWs in the facilities. A lack of a standardised ap-
proach to the responsibility for the provision of medi-
cines management services including the clinical review
of medicines and the provision of medication counsel-
ling was also identified. Despite holding positive views
of IC services, management of their medicines within
IC was not an area of concern for the majority of pa-
tients. Additionally, whilst pharmacists were not con-
sidered part of the multidisciplinary team, the majority
of HCWs identified a need for increased pharmacy in-
put. These issues are described in greater detail in the
following sections.
Concept and reality
HCWs noted that the concept of IC was not being fully
realised and several aspects of the reality of service
Table 2 Settings of IC facilities included in the study
Nursing home facilities (n = 5)
A more recent model of IC, these privately owned nursing home
facilities which, in addition to long-term nursing care, also provided IC
in varying numbers of beds purchased by the Trusts. Medical care
provision in these homes ranged from daily visits to ‘when required’
visits from a contracted GP (medical officer). In addition, three of the
facilities had weekly input from a consultant geriatrician.
Residential care home facilities (n = 3)
These facilities were Trust-owned residential care homes, staffed primarily
by healthcare assistants (support staff who provide basic care under the
guidance of qualified healthcare professionals). Of the three IC facilities in
this category, two managers had nursing backgrounds and one had a
social work background. There was less medical input in these facilities in
comparison to the other categories and medical cover was provided by
either the patients’ own GP or a local, contracted GP.
Non-acute hospital facilities (n = 4)
These were long-established facilities, sometimes referred to as ‘community
hospitals’, whose services pre-date the label of IC. One facility included in
this category functioned very much as a typical hospital ward with medical
cover provided 24/7 by Trust medical staff including junior doctors,
registrars and consultants. The three other facilities in this category also
had hospital ward-like environments, although medical cover was provided
on a day-time basis by local GPs whose practices were within the vicinity
of the facility.
Fig. 1 Interview schedule content (HCWs = healthcare workers; MDT =multi-disciplinary team)
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contrasted with the definition of IC. At the outset, the
term ‘intermediate care’ was not frequently used by inter-
viewees, with most identifying the service as ‘rehabilita-
tion’. Some participants commented that they avoided
using the term ‘IC’ as they viewed the terminology and
concept of IC to be poorly understood in the wider health
service:
“It’s a new word… I don’t like the term ‘intermediate
care’, I would sit more comfortable with it being a
medical rehabilitation ward for older people.” (HCW22)
“…the GPs (general practitioner) don’t know what the
heck it is. It’s a term that means all things to all men
and women and that’s the big difficulty.” (HCW24)
HCWs recognised that the preventative concept of IC
was not currently a reality. Despite the definition sug-
gesting that services should prevent unnecessary hospital
admissions in addition to providing ‘step-down’ care, IC
services were viewed as predominantly providing the lat-
ter, catering to patients following a period of care in an
acute hospital. The concept of IC being a targeted and
time-limited intervention of six weeks was contrasted
with a reality of prolonged lengths of stays in IC facil-
ities. HCWs noted that admissions to IC were often
inappropriate due to a lack of suitable alternatives and
pressures within hospitals to vacate beds:
“Quite often we would get a lot of social admissions
and how appropriate that is I’m not quite sure…we
can be used as a dumping ground.” (HCW6)
The concept that multidisciplinary working is funda-
mental to IC was met with the reality that there was no
standard approach to the structure of multidisciplinary
teams within IC, particularly in relation to medical care
provision and pharmacy involvement. Only two of the
twelve IC facilities received input from pharmacists and
the differences in medical care provision between IC
settings are highlighted in Table 2. The pharmacist par-
ticipants referred to challenges regarding integration
into the IC team:
“When I initially started, nursing staff certainly didn’t
know what my function was…they weren’t experienced
of what a clinical pharmacist would do…they couldn’t
get their head around a pharmacist being able to
prescribe or amend kardexes or give them advice.”
(HCW25)
Opinions held by HCWs on the overall concept and
effectiveness of the IC service differed depending on the
setting of the facility. HCWs within the non-acute
Table 3 Demographic profile of interview participants (n = 43)
Participanta Description IC facility setting Trust
HCW1 Home manager Residential home A
HCW2 Senior healthcare assistant Residential home A
P1 Female Residential home A
HCW3 Nurse Nursing home A
HCW4 Nurse Nursing home A
P2 Male Nursing home A
HCW5 Home manager Nursing home A
HCW6 Nurse Nursing home A
HCW7 Senior healthcare assistant Residential home A
HCW8 Senior healthcare assistant Residential home A
P3 Female Residential home A
P4 Male Residential home A
P5 Female Residential home A
HCW9 Home manager Nursing home A
HCW10 Nurse Nursing home A
HCW11 Nurse Nursing home A
P6 Female Nursing home A
P7 Male Nursing home A
HCW12 Home manager Residential home A
HCW13 Pharmacist Non-acute hospital B
HCW14 Nurse Non-acute hospital B
HCW15 Nurse Non-acute hospital B
P8 Female Non-acute hospital B
P9 Male Non-acute hospital B
HCW16 Nurse Non-acute hospital B
HCW17 Nurse Non-acute hospital B
HCW18 Nurse Non-acute hospital B
P10 Male Non-acute hospital B
P11 Female Non-acute hospital B
HCW19 Nurse Non-acute hospital B
P12 Male Non-acute hospital B
P13 Female Non-acute hospital B
HCW20 Nurse Nursing home C
HCW21 General Practitioner Nursing home C
P14 Male Nursing home C
P15 Female Nursing home C
HCW22 Nurse Non-acute hospital C
HCW23 Medical doctor Non-acute hospital C
P16 Male Non-acute hospital C
P17 Female Non-acute hospital C
P18 Male Non-acute hospital C
HCW24 Consultant Geriatrician Nursing home C
HCW25 Pharmacist Nursing home C
aKey: HCW = Healthcare worker, P = Patient
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hospital IC facilities held positive attitudes towards IC
services.
“I think it’s an invaluable service that we are providing.
Intermediate care to me is probably the gap between
acute service and a patient being allowed to be
discharged home …I do find it a very very invaluable
service really and it’s local, that means a lot to people
as well.” (HCW15)
However in the more recently established IC models
(within nursing and residential homes) opinions differed:
“…the definition is good, the concept is good…from the
top it looks okay but from the ground it is not running
properly.” (HCW5)
Contrastingly, the majority of patients expressed posi-
tive attitudes towards the IC setting and compared ser-
vices favourably to hospital environments. In particular,
they appreciated the homely atmosphere and locality of
the facilities and they viewed HCWs as having more
time for patient care.
“I think it’s this place that has helped me a lot…you
just feel like very at home already.” (P5)
Highlighted in the definition of IC are the concepts of
maximising patients’ independence and ‘person-centred
care’; however, with regards to medicines management,
there was evidence to suggest such principles were not
being promoted. Patients were often disempowered with
regards to their medicines, due to a distinct absence of
self-administration practices and a lack of provision of
education to encourage patient independence.
“There’s a fear of letting people… take control of their
own medication… this is an area we still haven’t
progressed very much from since the conception of the
service here.” (HCW1)
Setting and supply
The setting of the IC facilities was largely responsible
for the primary challenge encountered by some of the
facilities, namely the supply of medicines. The nature of
the three distinct care settings, as described previously
(see Table 2), dictated the medical care provision and
hence, the processes surrounding the prescribing and
supply of medicines. For instance, non-acute hospital
facilities kept supplies of medicines on the premises,
unlike the nursing and residential home IC facilities.
This, coupled with medical care provision operating
‘off-site’, meant that the process of the supply of
medicines to IC patients in such facilities was more lo-
gistically challenging.
“…it’s not seamless in any shape or form…you are
delaying the time from prescription being written to
the actual administration of that drug, so it’s very
clumsy, the whole management.” (HCW25)
The challenge of securing a prescriber was a barrier
unique to the nursing and residential home settings,
where medical care provision and hence, prescribing
responsibilities, fell to either the patients’ own GP, a
temporary GP local to the IC facility or a Trust-contracted
GP referred to as a ‘medical officer’. This variety of pre-
scribing arrangements often resulted in further confusion
regarding prescribing responsibilities. HCWs reported on
the challenges associated with such fragmented ap-
proaches to the prescribing and supply of medicines:
“It's complicated…if the [patient’s] GP refused to
prescribe scripts then…our temporary GP, would do it
and then he would send it over to this place…and then
they would send it to the [hospital pharmacy] and
then we would get the scripts from there. I know, it’s
very complicated.” (HCW10)
Many HCWs noted that such processes posed safety
risks to IC patients:
“…there has been times we have run out of medication
and we just haven’t been able to get it quick enough…
to keep the client…on their regular dose.” (HCW7)
The quantity of medications supplied at discharge at
the point of transfer from secondary care to IC was fre-
quently cited as problematic. Often, the supply of medi-
cines from the admitting hospital was insufficient.
“…diazepam…sleeping tablets, they’ll send you seven
tablets … those things that are on the PRN (to be
taken when required) side quite often they don’t even
send them out.” (HCW6)
Despite the range of difficulties encountered by HCWs,
the majority of patients had no knowledge of who was re-
sponsible for prescribing their medicines and had no con-
cerns surrounding their supply.
“They just give them to me, I don’t know where they
come from.” (P2)
When HCWs were asked to suggest potential solu-
tions to these barriers, the most frequently suggested
solution was to create a supply of medicines on-site,
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thus bypassing the inherent delays in sourcing medi-
cines from outside the IC setting. The alternative was
to ensure an adequate discharge supply of all medicines
from the admitting hospital and for community phar-
macies to increase their involvement with IC services.
Responsibility and review
The IC facility setting was the primary factor dictating re-
sponsibility for prescribing and review of patients’ medi-
cines. When asked whether medications were reviewed in
IC, HCWs noted that this was the responsibility of the
doctor. However, in the residential and nursing IC facil-
ities, HCWs reported that doctors visited infrequently,
sometimes only when requested by HCWs.
“We have people who come and don't be seen by the
doctor…they don't need to see a doctor.” (HCW7)
There was also an assumption amongst HCWs that pa-
tients’ medicines were reviewed in hospital, therefore a re-
view whilst in IC was considered unnecessary. Although
most reported not having concerns about their medicines,
those patients who wished to have their medications
reviewed spoke of the associated difficulties encountered.
“I’d got the chance to talk to [the doctor]… I really
just wanted off [the tablet]…I wasn’t impressed…I just
felt he wasn’t taking responsibility.” (P6)
In all but one facility, patient self-administration of med-
ications was uncommon. Despite this, most HCWs were
aware of the relationship between self-administration and
independence. However, linking back to the theme of
“concept and reality”, self-administration evoked patient
safety concerns. HCWs reasoned that to retain control
and responsibility for medicines administration was a sac-
rifice in terms of the disempowerment of some patients to
ensure safety for all.
“…it’s easier for us to just take control, take charge, we
know they’re safely stored, we know they’ve got them…”
(HCW1)
Both HCWs and patients referred to an expectation
amongst patients to be ‘nursed’ when in a healthcare en-
vironment, evidenced by the majority of patients readily
handing over responsibility of their medicines to staff.
However, one patient who had previously managed his
own medicines spoke of the resistance met from HCWs
when he requested to continue in IC.
“I think along the lines of 'that's how we do it here' just
plain and simple…I fairly soon realised it was a fight I
wasn’t going to win. It was bad.” (P7)
HCWs viewed the process of assessing patients’ abil-
ity to self-administer as time-consuming and incompat-
ible with IC, again highlighting the mismatch between
the concept and reality of IC. Responsibility surround-
ing the required authorisation was also identified as a
barrier to self-administration.
“We have to get the GP to sign that they’re happy
[for the patient to self-administer], but because they
come here under a temporary GP, Dr M will say
‘well I don’t know the person,’ so he won’t sign.”
(HCW12)
Medication counselling describes the practice of pro-
viding patients with information about their medicines
[13]. This was not considered a responsibility of any
HCW and, with the exception of those facilities with
pharmacists, would only be initiated at the patients’
request.
“…if you ask questions, you’ll be told, but you have to
enquire instead of being routinely told.” (P2)
Barriers included a perceived lack of medication know-
ledge amongst HCWs and views that providing medica-
tion counselling was redundant for patients who used
medication compliance aids.
“…patients come in here have maybe been getting
blister packs (a compliance aid) at home so there's no
point.” (HCW14)
Despite some patients having queries about their med-
icines, most were apathetic towards the idea of medica-
tion counselling.
“I'm one of those people who just takes the doctor’s
word for it and assume that he knows best and don't
really query it.” (P10)
The contrast in medicines management provision be-
tween facilities was most striking when comparing those
which had clinical pharmacy involvement and those that
did not. The majority of HCWs welcomed the idea of
pharmacy integration within the existing multidisciplin-
ary team.
“[Pharmacists] would be able to…look at the kardex
and see ‘why is this patient on this? Do they really
need to be on this?’ …when I worked in [hospital] it
was very beneficial, the pharmacist…done a lot of
teaching with the patients, even with the staff as well,
it was great to have somebody there to ask a question
if you needed to.” (HCW18)
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Contact with the pharmacy profession amongst most
of the facilities was via community pharmacy, with the
primary service being the supply of medicines. A minor-
ity of HCWs working in facilities without clinical phar-
macists did not see a role for the profession within IC
beyond the supply of medicines:
“… [Pharmacists’] input could be only on handling of
medication and storage of medications…but not really
like the MDT.” (HCW3)
Discussion
The aims of this study were to describe the current
provision of medicines management services in IC facil-
ities in NI and to determine HCWs’ and patients’ views
of and attitudes towards these services. This study un-
covered disparities between the concept of IC and many
aspects of the reality of the services. The setting in
which IC was provided was found to be a crucial factor in
determining prescribing responsibilities and consequently,
arrangements for the supply of medicines to patients. A
lack of a standardised approach to the provision of medi-
cines management services including the clinical review of
medicines was identified. The lack of integration of phar-
macists in IC was evident, and HCWs suggested that
increased pharmacy input could offer a potential solution
to the identified medicines management deficiencies.
The theme of ‘concept and reality’ symbolised the con-
trast between the key principles of IC and the service
reality. IC is a relatively new concept within the UK, yet
it has been integrated into the healthcare system in a
variety of models [14]. Community hospitals (non-acute
hospital facilities) represent one such model which pre-
date the term ‘IC’ but are increasingly being used as IC
facilities in the UK [15]. Despite this re-designation,
HCWs felt that although IC may be considered a new
concept, in reality, the service provided within such fa-
cilities remained largely unchanged, providing support
to the suggestion that the IC concept is ‘an old idea
rebranded’ [16]. Additionally, the confusion surrounding
terminology is not unique to NI and has been the sub-
ject of previous discussion in the literature [17].
The concept of IC describes services aimed at both
preventing unnecessary hospital admissions and provid-
ing ‘step-down’ care, however, in NI, the majority of
patients are admitted to IC following a period in hos-
pital. The preventative concept of IC is not being rea-
lised perhaps due to a lack of awareness of the role of
such services within the wider healthcare system. Disen-
gagement with and lack of awareness of IC on the part
of both GPs and hospital doctors has been highlighted
previously [16, 18]. The unfamiliarity of IC, coupled with
pressures faced by acute hospitals to discharge people
sooner may contribute to the reported inappropriate
admissions to IC in this study. There have been calls to
promote awareness among those who refer patients to
services, however, evidence is needed to support IC as a
care setting [19].
Another concept of IC is the multidisciplinary team.
In actuality, this study found that multidisciplinary
teams varied considerably between facilities, particularly
in relation to medical care provision and pharmacy
involvement. If IC is to be a service that seeks to address
all aspects of a patient’s care needs including their medi-
cines management needs, a standardised approach to
multidisciplinary team working and integration of phar-
macists is required. Despite these contrasts between the
concept of IC and the reality of the services, patients in
this study compared IC favourably to the traditional hos-
pital setting. The perceived benefits of IC for patients
were often linked to the ‘home-like’ environment of IC,
and have been described previously [20–22].
The theme of ‘setting and supply’ illustrates the impact
of the IC setting on medicines management provision
and specifically, the supply of medicines. The settings in
which IC was delivered within NI were found to be var-
ied, differing not only in the care environment but also
the medicines management processes within. The supply
of medicines was by far the most frequently voiced
medicine-related concern amongst IC staff. Securing a
prescription and obtaining medicines from a pharmacy,
where a supply was unavailable on-site, presented many
difficulties for HCWs. Such gaps in continuity of care have
been associated with adverse patient outcomes [23–25].
Conversely, in the non-acute hospital facilities where both
prescribers and medicine stock were accessible on-site,
such supply issues were practically non-existent. A solu-
tion suggested by many HCWs, was to have medication
stock available in all IC facilities, thereby eradicating the
logistical barriers described. The difficulty with such a
proposal would be the requirement for a significant
change in the longstanding medication supply arrange-
ments within the nursing and residential homes. Nonethe-
less, it is evident that the current mode of medication
supply within such facilities is not effectively catering for
IC patients.
Responsibility for prescribing and reviewing patients’
medicines in the IC facilities varied depending on the
setting. There was no standardised approach to the re-
view of patients’ medicines and in the majority of facil-
ities, HCWs noted that medication reviews were not
conducted unless explicitly requested. This therefore
poses a risk that medication discrepancies and/or ADEs
may go undetected amongst older adults in IC facilities.
Another barrier to medication review was the assumption
of medication optimisation in the acute setting. Caring for
older people in residential and nursing home settings is
known to have significant workload implications for GPs
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responsible for their care [26]. The reluctance of GPs to
visit patients in institutional settings has been discussed
previously and factors such as a desire amongst GPs to
maintain strict practice boundaries and the perceived triv-
ial nature of visiting requests have been cited as barriers
to the provision of general medical services to older
people in these settings [27].
Self-administration of medicines was not promoted in
the IC setting. HCWs represented the main barrier to
self-administration as they felt the need to be in control
of patients’ medicines, citing patient safety as their pri-
mary concern. Further resistance to self-administration
of medicines came from patients themselves, who were
happy to let staff take control of their medicines. There
was an expectation among patients of the loss of auton-
omy when entering a healthcare facility. The same
power dynamic between healthcare staff and patients
has been described in the traditional nursing home
setting [28]. Self-administration of medicines is syn-
onymous with encouraging independence and thus
patient empowerment, which itself is associated with
improved healthcare outcomes [29]. Specifically, self-
administration programmes have been shown to improve
compliance with and knowledge of patients' medications
post hospital discharge [30, 31]. Despite patients’ indiffer-
ent attitudes towards self-administration in this study, it
has been demonstrated that following participation in a
self-administration programme, the vast majority of pa-
tients report a preference for this method over usual nurse
administration of medicines [30]. In order to successfully
implement self-administration programmes with the view
of increasing patient independence, there needs to be a re-
examination and acknowledgement of responsibility from
not only HCWs but patients as well.
Medication counselling was not routinely provided to
patients in IC. A perceived lack of confidence amongst
HCWs surrounding knowledge of medications and a
view that many older people would not benefit from
medication counselling were the two main barriers de-
scribed. Similar findings have been discussed previously
with the result of nurse-patient communications being
criticised for often being brief and superficial in nature
[32]. Patients’ attitudes proved to be an additional bar-
rier to medication counselling, with many feeling it was
simply unnecessary. Medication counselling should be
an integral part of patient care, especially in the IC set-
ting where patients are rehabilitating and regaining skills
to ensure their independence. Patient education has
been shown to improve patients’ ability to remain au-
tonomous with their medications and is frequently a part
of interventions aimed at improving adherence to medi-
cines [33]. It has also been associated with a decreased
incidence of avoidable adverse drug events post hospital
discharge [13], therefore the importance of increasing
patients’ understanding of their medicines in the IC set-
ting cannot be underestimated considering that the goal
of IC is to promote independence.
Facilitating the supply of medicines, reviewing medi-
cines [34], promoting self-administration [35], and medi-
cation counselling [36] are all roles associated with
pharmacists. However, it was evident that pharmacists
were not integrated members of the IC multidisciplinary
team as the pharmacy presence throughout the facilities
was minimal. Most facilities referred to community
pharmacists as being their sole pharmacy contact who
served only to facilitate the supply of medicines. The
clinical pharmacists who assumed enhanced pharmacist
roles in IC experienced challenges integrating as part of
the multidisciplinary team. This may be due to a lack of
awareness of the pharmacists’ role, which has previously
been identified as a barrier to pharmacist integration in
such team [37]. In those facilities without clinical phar-
macy input, staff readily identified a range of roles for
pharmacists that were currently being unmet. These in-
cluded medicines reconciliation, liaising with primary
and secondary care stakeholders, medicines appropriate-
ness reviews and patient and staff education. Conversely,
a minority of HCWs could not see a role for pharmacists
in IC, despite identifying several unresolved medicines
management challenges. Again, such views may be due
to a misunderstanding of the role and stereotypical busi-
ness orientated image traditionally associated with the
profession [38]. There is, therefore, a need for more
work to evaluate the role of pharmacists within IC and
to raise awareness of the roles of clinical pharmacists.
Strengths and limitations
This was the first study of its kind to report on the issue
of medicines management in the IC setting. As it was
qualitative in nature, the results are not intended to be
generalizable to all IC facilities. Participation was volun-
tary, therefore it is possible that the views expressed
reflected those with an interest in medicines manage-
ment, however, data saturation was attained with our
sample size and the views described were representative
of those held by the majority of the participants. Finally,
validation checks were conducted using a second re-
searcher and consensus within the team on the final
themes.
Conclusion
The expected rise in the number and proportion of older
people living with chronic conditions and taking mul-
tiple medicines will put additional pressure on acute ser-
vices in the coming decades. IC has been introduced in
the UK as one part of the solution to managing this
increasing pressure. IC facilities in NI include older estab-
lished services provided within non-acute hospital settings
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and more recently, beds within nursing and residential
homes. The latter two IC models are fraught with medi-
cines management issues, some of which may pose safety
risks to patients. The lack of pharmacy input into the IC
setting has been exposed and the potential roles for phar-
macists highlighted. IC provides an ideal setting for pa-
tients to regain independence and this should also include
managing their medicines. Pharmacists are ideally placed
to provide advice to both IC staff and patients alike and
their skills could be utilised to review medications for ap-
propriateness and help to ensure a seamless transition of
care across this healthcare interface. Further work is re-
quired to define and evaluate how pharmacists can inte-
grate with IC services.
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